Meet Chunde Li – Chundsell Medical

Published 17 June, 2019 | Innovations from KI

He is behind a unique test to distinguish benign prostate cancer from
aggressive forms of the condition that require immediate treatment. Finding
the right contacts at the right time was key to the success of the project.

Chunde Li came to Karolinska Institutet as a guest researcher in 1993 from China. Initially, the plan had been to return home after getting his doctorate, or move on to the US. But in the end he stayed in Sweden and set up Chundsell Medical after having identified a method that distinguishes between aggressive and low risk prostate cancers and can therefor be a complement to screening.

“I’m driven by seeing my patients on a daily basis. I want to be able to give them the best choice among current treaments or even new effective treatments in the future”, says Li

If you want to read more about Chunde Li and Chundsell Medical you can find the entire interview in our booklet 20 Years of innovation @ Karolinska Institutet

He is behind a unique test to distinguish benign prostate cancer from aggressive forms of the condition that require immediate treatment. Finding the right contacts at the right time was key to the success of the project.

He is behind a unique test to distinguish benign prostate cancer from
aggressive forms of the condition that require immediate treatment. Finding
the right contacts at the right time was key to the success of the project.